Predictors of anaphylaxis to peanut and tree nuts in a Mediterranean population

Allergy Asthma Proc. 2022 Nov 1;43(6):533-542. doi: 10.2500/aap.2022.43.220060.

Abstract

Background: Peanuts (PN) and tree nuts (TN) are major causes of anaphylaxis worldwide. We aimed to determine the clinical and demographic characteristics associated with anaphylaxis in patients sensitized to PN and/or TN in a Mediterranean population. Methods: We conducted a retrospective study, which included 198 patients allergic to PN and/or TN (allergy symptoms plus specific immunoglobulin E [sIgE] sensitization), evaluated in consultations from January 2015 to December 2020. Univariate analysis and multivariate logistic regression models were developed, including demographic, clinical, and laboratory data as independent variables, and anaphylaxis to each PN and/or TN as a dependent variables. Results: Anaphylaxis was associated with an earlier age of onset of allergy to PN, cashew and/or pistachio, and pine nut allergy but not to other TN allergies. Gender, atopic comorbidities, and cofactors were not associated with PN and/or TN anaphylaxis. Anaphylaxis to PN, cashew and/or pistachio, and pine nut were associated with reactivity to a fewer number of PN and/or TN foods. Although sIgE sensitization to lipid transfer proteins (LTP) was highly prevalent in our population, only seed storage protein (SSP) positivity was associated with anaphylaxis in PN allergy. The absence of pathogenesis-related protein family 10 sensitization correlated with PN and hazelnut anaphylaxis. A higher level of sIgE to almond extract predicted anaphylaxis but the level of sIgE to other PN and/or TN extracts did not predict it. Conclusion: The high prevalence of sensitization to the pan-allergen LTP did not seem to have a significant impact in PN and/or TN allergy severity in our study. Instead, other factors, such as early age of onset and positivity for SSPs, seem to strongly associate with anaphylaxis to specific PN and/or TN. These findings may contribute to individual risk assessment in these populations.

MeSH terms

  • Allergens
  • Anaphylaxis* / diagnosis
  • Anaphylaxis* / epidemiology
  • Anaphylaxis* / etiology
  • Arachis
  • Humans
  • Immunoglobulin E
  • Nut Hypersensitivity* / diagnosis
  • Nut Hypersensitivity* / epidemiology
  • Nuts / adverse effects
  • Peanut Hypersensitivity* / diagnosis
  • Peanut Hypersensitivity* / epidemiology
  • Retrospective Studies

Substances

  • Immunoglobulin E
  • Allergens